Paediatric asthma and pneumococcal vaccination

Vaccine

Volumn 31, Issue 44, 2013, Pages 5015-5019

  Esposito, Susanna ^a   Musio, Alessandra ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Adolescents; Asthma; Children; Pneumococcal conjugate vaccine; Pneumococcal vaccine; Streptococcus pneumoniae

Indexed keywords

BECLOMETASONE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ANTIBIOTIC PROPHYLAXIS; ASTHMA; DISEASE PREDISPOSITION; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; TREATMENT DURATION;

ADOLESCENTS; ASTHMA; CHILDREN; PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMOCOCCAL VACCINE; STREPTOCOCCUS PNEUMONIAE;

ADRENAL CORTEX HORMONES; ADVISORY COMMITTEES; ASTHMA; CHILD; HUMANS; IMMUNIZATION SCHEDULE; PEDIATRICS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RISK FACTORS; VACCINATION;

EID: 84885422888     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.08.090     Document Type: Review

References (45)

1. Zangeneh T.T., Baracco G., Al-Tawfiq J.A. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections. Expert Rev Vaccines 2011, 10:345-353.
2. Tan T.Q. Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA. Expert Rev Anti Infect Ther 2010, 8:117-125.
3. Burman L.A., Norrby R., Trollfors B. Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis 1985, 7:133-142.
4. Laupland K.B., Davies H.D., Kellner J.D., Luzod N.L., Karan T., Ma D., et al. Predictors and outcome of admission for invasive Streptococcus pneumoniae infections at a Canadian children's hospital. Clin Infect Dis 1998, 27:597-602.
5. Kaplan S.L., Mason E.O., Wald E., Tan T.Q., Schutze G.E., Bradley J.S., et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 2002, 21:141-147.
6. Grant C.C., Harnden A.R., Jewell G., Knox K., Peto T.E., Crook D.W. Invasive pneumococcal disease in Oxford, 1985-2001: a retrospective case series. Arch Dis Child 2003, 88:712-714.
7. Hsu K., Pelton S., Karumuri S., Heisey-Grove D., Klein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J 2005, 24:17-23.
8. Berg S., Trollfors B., Persson E., Backhaus E., Larsson P., Ek E., et al. Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis 2006, 38:427-432.
9. Hjuler T., Wohlfahrt J., Staum Kaltoft M., Koch A., Biggar R.J., Melbye M. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008, 122:e26-e32.
10. Robinson K.A., Baughman W., Rothrock G., Barrett N.L., Pass M., Lexau C., et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285:1729-1735.
11. Mason E.O, Wald E.R., Tan T.Q., Schutze G.E., Bradley J.S., Barson W.J., et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J 2007, 26:480-484.
12. Centers for Disease Control and Prevention Prevention of pneumococcal disease among infants and children - Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. Recommendations of Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(RR-11):1-20.
13. National Health System Pneumococcal vaccines. Available at: ; 2013 [accessed 22.03.13]. http://www.nhs.uk/Conditions/vaccinations/Pages/pneumococcal-vaccination.aspx.
14. Institut National de Veille Sanitaire Calendrier des vaccinations et les raccomandations vaccinales. Bull Hepidemiol Hebdo 2010, 1415:121-171.
15. Picard C., Puel A., Bustamante J., Ku C.L., Casanova J.L. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 2003, 3:451-459.
16. Ku C.L., Picard C., Erdös M., Jeurissen A., Bustamante J., Puel A., et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2007, 44:16-23.
17. Klugman K.P., Madhi S.A., Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007, 20:11-15.
18. Schutze G.E., Mason E.O., Barson W.J., Kim K.S., Wald E.R., Givner L.B., et al. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J 2002, 21:278-282.
19. Ellison A.M., Ota K.V., McGowan K.L., Smith-Whitley K. Epidemiology of bloodstream infections in children with sickle cell disease. Pediatr Infect Dis J 2013, 32:560-563. [Epub Jan 21].
20. Tan J.S., Anderson J.L., Watanakunakorn C., Phair J.P. Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med 1975, 85:26-33.
21. Kemper M.J., Altrogge H., Ganschow R., Müller-Wiefel D.E. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatr Nephrol 2002, 17:413-417.
22. Talbot T.R., Hartert T.V., Mitchel E., Halasa N.B., Arbogast P.G., Poehling K.A., et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005, 352:2082-2090.
23. Juhn Y.J., Kita H., Yawn B.P., Boyce T.G., Yoo K.H., McGree M.E., et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol 2008, 122:719-723.
24. Klemets P., Lyytikäinen O., Ruutu P., Ollgren J., Kaijalainen T., Leinonen M., et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 2010, 65:698-702.
25. Centers for Disease Control and Prevention Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012, 61(RR-40):816-819.
26. National Asthma Education and Prevention Program Expert Panel report: guidelines for the diagnosis and management of asthma update on selected topics - 2002. J Allergy Clin Immunol 2002, 110(Suppl. 5):S141-S219. [Erratum, J Allergy Clin Immunol 2003; 111:466].
27. Centers for Disease Control and Prevention Prevention of pneumococcal disease - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997, 46(RR-8):1-24.
28. Centers for Disease Control and Prevention Preventing pneumococcal disease among infants and young children - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000, 49(RR-9):1-35.
29. Folli C., Descalzi D., Scordamaglia F., Riccio A.M., Gamalero C., Canonica G.W. New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol 2008, 8:367-375.
30. Blair C., Nelson M., Thompson K., Boonlayangoor S., Haney L., Gabr U., et al. Allergic inflammation enhances bacterial sinusitis in mice. J Allergy Clin Immunol 2001, 108:424-429.
31. Zhang L., Prietsch S.O., Mendes A.P., Von Groll A., Rocha G.P., Carrion L., et al. Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma. Respirology 2013, 18:272-277.
32. Haby M.M., Peat J.K., Marks G.B., Woolcock A.J., Leeder S.R. Asthma in preschool children: prevalence and risk factors. Thorax 2001, 56:589-595.
33. Rose M.A., Schubert R., Kujumdshiev S., Kitz R., Zielen S. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma. Int J Clin Pract 2006, 60:1425-1431.
34. Bisgaard H., Hermansen M.N., Buchvald F., Loland L., Halkjaer L.B., Bønnelykke K., et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007, 357:1487-1495.
35. Jung J.A., Kita H., Dhillon R., Jacobson R.M., Nahm M.H., Park M., et al. Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med 2010, 122:116-124.
36. Maintz L., Novak N. Modifications of the innate immune system in atopic dermatitis. J Innate Immun 2011, 3:131-141.
37. Arkwright P.D., Patel L., Moran A., Haeney M.R., Ewing C.I., David T.J. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine. Clin Exp Immunol 2000, 122:16-19.
38. Jung J.A., Kita H., Yawn B.P., Boyce T.G., Yoo K.H., McGree M.E., et al. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol 2010, 125:217-221.
39. De Schutter I., Dreesman A., Soetens O., De Waele M., Crokaert F., Verhaegen J., et al. In young children, persistent wheezing is associated with bronchial bacterial infection: a retrospective analysis. BMC Pediatr 2012, 12:83.
40. Schwerk N., Brinkmann F., Soudah B., Kabesch M., Hansen G. Wheeze in preschool age is associated with pulmonary bacterial infection and resolves after antibiotic therapy. PLoS ONE 2011, 6:e27913.
41. Rose M.A., Gruendler M., Schubert R., Kitz R., Schulze J., Zielen S. Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics. Vaccine 2009, 27:5259-5264.
42. Törling J., Hedlund J., Konradsen H.B., Ortqvist A. Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. Vaccine 2003, 22:96-103.
43. Jackson L.A., Neuzil K.M., Nahm M.H., Whitney C.G., Yu O., Nelson J.C., et al. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 2007, 25:402937.
44. Borrow R. The evidence for use of pneumococcal conjugate over polysaccharide in children. Hum Vaccin Immunother 2013, 9. Epub May 31.
45. Hedlin G., Konradsen J., Bush A. An update on paediatric asthma. Eur Respir Rev 2012, 21:175-185.